Genetic fingerprints help predict sarcoma outcome:
This article was originally published in Clinica
US researchers have developed a genetic fingerprint of each type of adult soft tissue sarcoma, which they say will improve their diagnosis and enhance the prediction of patient outcome. The genetic fingerprints, which were identified using oligonucleotide array analysis, will be useful in cases where pathologists disagree about a diagnosis or when the appearance of tumour cells does not conclusively link them to a particular subtype, say researchers led by Dr Robert Maki, of the Memorial Sloan-Kettering Cancer Center in New York.